Westlake Village, United States
Rx-Precision, Inc. is a clinical genomics risk case management firm that specializes in precision medical management. Founded in 2017, the company focuses on integrating Pharmacogenomics (PGx) and Precision Medicine to reduce risk, lower costs, and improve outcomes in high genomic-risk populations. By developing systems around the science of genomics and processes around the commercial market, they provide end-to-end solutions for their clients.
Combining data integration and analytics, risk stratification, genetic analysis, clinical genomic support, and data research on outcomes, Rx-Precision addresses key issues related to integration of PGx and Precision Medicine, offering a Risk Identification Application, Clinical Automation, and Robust Data Research and Outcome Reporting.
The company serves a wide range of clients including Plan Administrators, Fiduciaries, Third Party Administrators, Brokers, Population Health Companies, Pharmacy Benefit Managers, Self-Funded Employers, Health Plans, CIN's, Health Care Systems, Genomic Laboratories, Life, Disability and Voluntary Benefit Carriers, ERISA Law Firms, Physicians, and Integrative Medical Practices.
Rx-Precision is notably proud of its partner lab, a CLIA-certified and CAP-accredited laboratory for the development, validation, and delivery of proprietary laboratory developed tests (LDTs).
This innovative venture offers a promising opportunity for investors seeking involvement in the health care, pharmaceutical, and health insurance industries.
